Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karima Farhat

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
NDT Plus|May 19, 2015
Conventional versus biocompatible peritoneal dialysis fluids: more questions than answers?Karima Farhat, Frans Jan van Ittersum, Piet Marten Ter Wee, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 15, 2014
Pharmacologic targets and peritoneal membrane remodelingKarima Farhat, Andrea W D Stavenuiter, Rob H J Beelen, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|September 25, 2007
The first weeks on peritoneal dialysis: effects on clinical parametersKarima Farhat, Frans J van Ittersum, Paolo Fabbrini, et al.
International Journal of Nephrology|August 10, 2011
Bioincompatible impact of different peritoneal dialysis fluid components and therapeutic interventions as tested in a rat peritoneal dialysis modelAndrea W D Stavenuiter, Karima Farhat, Margot N Schilte, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 29, 2017
Effects of Conversion to a Bicarbonate/Lactate-Buffered, Neutral-pH, Low-GDP PD Regimen in Prevalent PD: A 2-Year Randomized Clinical TrialKarima Farhat, Caroline E Douma, E Ferrantelli, et al.
Clinical Nephrology|October 11, 2017
Initiation of peritoneal dialysis in the first weeks after catheter insertion: A comparison of a neutral-pH, low-GDP PD fluid and a conventional PD fluid
Karima Farhat, Frans J van Ittersum, Pieter M Ter Wee, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 2, 2018
Effects of Oral Paricalcitol and Calcitriol Treatment on Peritoneal Membrane Characteristics of Peritoneal Dialysis Patients - A Pilot StudyKarima Farhat, Andrea W D Stavenuiter, Marc G Vervloet, et al.
Scientific Reports|January 19, 2018
Effluent and serum protein N-glycosylation is associated with inflammation and peritoneal membrane transport characteristics in peritoneal dialysis patientsEvelina Ferrantelli, Karima Farhat, Agnes L Hipgrave Ederveen, et al.
Biomed Research International|November 26, 2015
Protective Effects of Paricalcitol on Peritoneal Remodeling during Peritoneal DialysisAndrea W D Stavenuiter, Karima Farhat, Marc Vila Cuenca, et al.
Journal of Personalized Medicine|July 27, 2022
Validation of Two Screening Tools for Anxiety in Hemodialysis PatientsEls Nadort, Noëlle J K van Geenen, Robbert W Schouten, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
NDT Plus|May 19, 2015
Conventional versus biocompatible peritoneal dialysis fluids: more questions than answers?Karima Farhat, Frans Jan van Ittersum, Piet Marten Ter Wee, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 15, 2014
Pharmacologic targets and peritoneal membrane remodelingKarima Farhat, Andrea W D Stavenuiter, Rob H J Beelen, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|September 25, 2007
The first weeks on peritoneal dialysis: effects on clinical parametersKarima Farhat, Frans J van Ittersum, Paolo Fabbrini, et al.
International Journal of Nephrology|August 10, 2011
Bioincompatible impact of different peritoneal dialysis fluid components and therapeutic interventions as tested in a rat peritoneal dialysis modelAndrea W D Stavenuiter, Karima Farhat, Margot N Schilte, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 29, 2017
Effects of Conversion to a Bicarbonate/Lactate-Buffered, Neutral-pH, Low-GDP PD Regimen in Prevalent PD: A 2-Year Randomized Clinical TrialKarima Farhat, Caroline E Douma, E Ferrantelli, et al.
Clinical Nephrology|October 11, 2017
Initiation of peritoneal dialysis in the first weeks after catheter insertion: A comparison of a neutral-pH, low-GDP PD fluid and a conventional PD fluid
Karima Farhat, Frans J van Ittersum, Pieter M Ter Wee, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 2, 2018
Effects of Oral Paricalcitol and Calcitriol Treatment on Peritoneal Membrane Characteristics of Peritoneal Dialysis Patients - A Pilot StudyKarima Farhat, Andrea W D Stavenuiter, Marc G Vervloet, et al.
Scientific Reports|January 19, 2018
Effluent and serum protein N-glycosylation is associated with inflammation and peritoneal membrane transport characteristics in peritoneal dialysis patientsEvelina Ferrantelli, Karima Farhat, Agnes L Hipgrave Ederveen, et al.
Biomed Research International|November 26, 2015
Protective Effects of Paricalcitol on Peritoneal Remodeling during Peritoneal DialysisAndrea W D Stavenuiter, Karima Farhat, Marc Vila Cuenca, et al.
Journal of Personalized Medicine|July 27, 2022
Validation of Two Screening Tools for Anxiety in Hemodialysis PatientsEls Nadort, Noëlle J K van Geenen, Robbert W Schouten, et al.
Pageof 2